|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brody H: Colorectal cancer. Nature.
521:S12015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bateman BT and Kesselheim AS: Propofol as
a transformative drug in anesthesia: Insights from key early
investigators. Drug Discov Today. 20:1012–1017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang S, Liu Y, Huang L, Zhang F and Kang
R: Effects of propofol on cancer development and chemotherapy:
Potential mechanisms. Eur J Pharmacol. 831:46–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu ZF, Lee MS, Wong CS, Lu CH, Huang YS,
Lin KT, Lou YS, Lin C, Chang YC and Lai HC: Propofol-based total
intravenous anesthesia is associated with better survival than
desflurane anesthesia in colon cancer surgery. Anesthesiology.
129:932–941. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren YL and Zhang W: Propofol promotes
apoptosis of colorectal cancer cells via alleviating the
suppression of lncRNA HOXA11-AS on miRNA let-7i. Biochem Cell Biol.
98:90–98. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hickman JA: Apoptosis induced by
anticancer drugs. Cancer Metastasis Rev. 11:121–139. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mohammad RM, Muqbil I, Lowe L, Yedjou C,
Hsu HY, Lin LT, Siegelin MD, Fimognari C, Kumar NB and Dou QP:
Broad targeting of resistance to apoptosis in cancer. Semin Cancer
Biol. 35:S78–S103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hassannia B, Vandenabeele P and Berghe TV:
Targeting ferroptosis to iron out cancer. Cancer Cell. 35:830–849.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C
and Li B: Ferroptosis, a new form of cell death: Opportunities and
challenges in cancer. J Hematol Oncol. 12:342019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang
Y, Luo A, Zhang K, Duan X and Wang Y: Targeting SLC7A11
specifically suppresses the progression of colorectal cancer stem
cells via inducing ferroptosis. Eur J Pharm Sci. 152:1054502020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sui X, Zhang R, Liu S, Duan T, Zhai L,
Zhang M, Han X, Xiang Y, Huang X, Lin H and Xie T: RSL3 drives
ferroptosis through GPX4 inactivation and ROS production in
colorectal cancer. Front Pharmacol. 9:13712018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Liu W, Liu F, Wang Q, Song M, Yu
Q, Tang K, Teng T, Wu D, Wang X, et al: IMCA induces ferroptosis
mediated by SLC7A11 through the AMPK/mTOR pathway in colorectal
cancer. Oxid Med Cell Longev. 2020:16756132020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang WZ, Jan CR and Lu CH: Investigation
of 2,6-diisopropylphenol (propofol)-evoked Ca2+ movement and cell
death in human glioblastoma cells. Toxicol In Vitro. 26:862–871.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Zhao L, Wu J, Hong J and Wang S:
Propofol induces ROS-mediated intrinsic apoptosis and migration in
triple-negative breast cancer cells. Oncol Lett. 20:810–816. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou B, Liu J, Kang R, Klionsky DJ,
Kroemer G and Tang D: Ferroptosis is a type of autophagy-dependent
cell death. Semin Cancer Biol. 66:89–100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Zhu M, Mohan SK and Hao Z: Crocin
treatment promotes the oxidative stress and apoptosis in human
thyroid cancer cells FTC-133 through the inhibition of STAT/JAK
signaling pathway. J Biochem Mol Toxicol. 35:e226082021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu Z: Surgical treatment of colorectal
cancer. Chin Oncol. 23:389–398. 2013.(In Chinese).
|
|
22
|
Cassinello F, Prieto I, del Olmo M, Rivas
S and Strichartz GR: Cancer surgery: How may anesthesia influence
outcome? J Clin Anesth. 27:262–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang C, Zhang X, Yang M and Dong X:
Recent progress in ferroptosis inducers for cancer therapy. Adv
Mater. 31:e19041972019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Trujillo-Alonso V, Pratt EC, Zong H,
Lara-Martinez A, Kaittanis C, Rabie MO, Longo V, Becker MW, Roboz
GJ, Grimm J and Guzman ML: FDA-approved ferumoxytol displays
anti-leukaemia efficacy against cells with low ferroportin levels.
Nat Nanotechnol. 14:616–622. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lo M, Ling V, Low C, Wang YZ and Gout PW:
Potential use of the anti-inflammatory drug, sulfasalazine, for
targeted therapy of pancreatic cancer. Curr Oncol. 17:9–16. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Shi J, Liu X, Feng L, Gong Z,
Koppula P, Sirohi K, Li X, Wei Y, Lee H, et al: BAP1 links
metabolic regulation of ferroptosis to tumour suppression. Nat Cell
Biol. 20:1181–1192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu S, Zhang Q, Sun X, Zeh HJ III, Lotze
MT, Kang R and Tang D: HSPA5 regulates ferroptotic cell death in
cancer cells. Cancer Res. 77:2064–2077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang H, Chen D, Li C, Zheng C, Wu X, Zhang
Y, Song Q and Fei W: Dual GSH-exhausting sorafenib loaded
manganese-silica nanodrugs for inducing the ferroptosis of
hepatocellular carcinoma cells. Int J Pharm. 572:1187822019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang K, Zhang Z, Wang M, Cao X, Qi J, Wang
D, Gong A and Zhu H: Role of GRP78 inhibiting artesunate-induced
ferroptosis in KRAS mutant pancreatic cancer cells. Drug Des Dev
Ther. 13:2135–2144. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W and
Wang J: Molecular mechanisms of ferroptosis and its role in cancer
therapy. J Cell Mol Med. 23:4900–4912. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xiao X, Jiang Y, Liang W, Wang Y, Cao S,
Yan H, Gao L and Zhang L: miR-212-5p attenuates ferroptotic
neuronal death after traumatic brain injury by targeting Ptgs2. Mol
Brain. 12:782019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Q, Han X, Lan X, Gao Y, Wan J, Durham
F, Cheng T, Yang J, Wang Z, Jiang C, et al: Inhibition of neuronal
ferroptosis protects hemorrhagic brain. JCI Insight. 2:e907772017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Lu Y, Pang Y, Li M, Cheng X and Chen
J: Propofol enhances the cisplatin-induced apoptosis on cervical
cancer cells via EGFR/JAK2/STAT3 pathway. Biomed Pharmacother.
86:324–333. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Y, Zuo Y, Li B, Xie J, Ma Z,
Thirupathi A, Yu P, Gao G, Shi M, Zhou C, et al: Propofol prevents
oxidative stress and apoptosis by regulating iron homeostasis and
targeting JAK/STAT3 signaling in SH-SY5Y cells. Brain Res Bull.
153:191–201. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang YF, Li CS, Zhou Y and Lu XH: Effects
of propofol on colon cancer metastasis through STAT3/HOTAIR axis by
activating WIF-1 and suppressing wnt pathway. Cancer Med.
9:1842–1854. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu S, Sechi M, Singh PK, Dai L, McCann S,
Sun D, Ljungman M and Neamati N: A novel redox modulator induces a
GPX4-mediated cell death that is dependent on iron and reactive
oxygen species. J Med Chem. 63:9838–9855. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brown CW, Amante JJ, Goel HL and Mercurio
AM: The α6β4 integrin promotes resistance to ferroptosis. J Cell
Biol. 216:4287–4297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Q and Wang K: The induction of
ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the
sensitivity of osteosarcoma cells to cisplatin. Cell Biol Int.
43:1245–1256. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang GY, Yang WH and Chen Z: Upregulated
STAT3 and RhoA signaling in colorectal cancer (CRC) regulate the
invasion and migration of CRC cells. Eur Rev Med Pharmacol Sci.
20:2028–2037. 2016.PubMed/NCBI
|
|
42
|
Zhao FL and Qin CF: EGF promotes HIF-1α
expression in colorectal cancer cells and tumor metastasis by
regulating phosphorylation of STAT3. Eur Rev Med Pharmacol Sci.
23:1055–1062. 2019.PubMed/NCBI
|
|
43
|
Zhang WJ, Hu CG, Luo HL and Zhu ZM:
Activation of P2×7 receptor promotes the invasion and migration of
colon cancer cells via the STAT3 signaling. Front Cell Dev Biol.
8:5865552020. View Article : Google Scholar : PubMed/NCBI
|
